| 1 | Approve Financial Statements | For |
| 2 | Approve the Remuneration Report | Abstain |
| 3 | Discharge the Board | For |
| 4 | Approve the Dividend | For |
| 5 | Approve the Special Dividend | For |
| 6.1 | Approve Fees Payable to the Board of Directors | For |
| 6.2 | Approve Executive Board compensation | Abstain |
| 7 | Approve Authority to Increase Authorised Share Capital | For |
| 8 | Increase Conditional Capital | For |
| 9.1.1 | Re-elect Dr. Elisabeth Bourqui | For |
| 9.1.2 | Re-elect Christopher M. Chambers | Abstain |
| 9.1.3 | Re-elect Dr. Rudolf Huber | For |
| 9.1.4 | Re-elect Mario F. Seris | For |
| 9.1.5 | Re-elect Klaus R. Wecken | For |
| 9.1.6 | Re-elect Prof. Dr. Hans Peter Wehrli | For |
| 9.1.7 | Elect Barbara Frei-Spreiter | For |
| 9.1.8 | Elect Thomas Studhalter | For |
| 9.2 | Re-elect Prof. Dr. Hans Peter Wehrli as Chairman of the Board of Directors | Abstain |
| 9.3.1 | Re-elect Dr. Elisabeth Bourqui as member of the Nomination and Rumeration Committee | For |
| 9.3.2 | Re-elect Christopher M.Chambers as member of the Nomination and Rumeration Committee | Abstain |
| 9.3.3 | Re-elect Mario F. Serisas member of the Nomination and Rumeration Committee | Oppose |
| 9.3.4 | Elect Remuneration/Audit Committee Member election of Dr. Barbara Frei-Spreiter as a new member of the Nomination and Compensation Committee | For |
| 9.4 | Appoint Independent Proxy | For |
| 9.5 | Appoint the Auditors | Oppose |
